The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Women with a history of breast cancer or ductal carcinoma in situ (DCIS) undergo ...

MONTREAL--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leader in breast health technology and diagnostics, will feature its latest breast cancer detection technology during the 2024 Society of ...

Mammography screenings are the cornerstone for screening women for breast cancer, but they often do not detect small tumors or tumors in women with dense breasts. That’s why other imaging tools such ...

Bayer and Hologic have teamed up with the goal of offering clearer breast cancer scans as a package deal—combining the former’s imaging contrast agents with the latter’s mammography hardware. The two ...

SAN ANTONIO — Contrast-enhanced digital mammography is comparable to breast MRI in evaluating residual breast cancer after neoadjuvant endocrine therapy or chemotherapy, according to the results of a ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer and Hologic, Inc. (Nasdaq: HOLX) today announced a first-of-its-kind collaboration to deliver a coordinated solution for contrast-enhanced mammography (CEM). The ...

Quality-assurance specialist CIRS has teamed up with GE Healthcare to commercialize an easy-to-use breast-equivalent phantom for contrast-enhanced spectral mammography Complementary capabilities: when ...

Northwest Hospital now has a new tool to help staff and patients fight against breast cancer. In May, the Randallstown-based facility implemented contrast enhanced mammography. This new service ...

According to the ARRS American Journal of Roentgenology (AJR), contrast-enhanced mammography (CEM) may be a useful alternative test for neoadjuvant therapy (NAT) response assessment in patients with ...

According to ARRS' American Journal of Roentgenology (AJR), contrast-enhanced mammography (CEM) showed concordance with MRI in women with newly diagnosed breast cancer and breast augmentation. Noting ...

Contrast-enhanced digital mammography is comparable to breast MRI in evaluating residual breast cancer after neoadjuvant endocrine therapy or chemotherapy, according to new results. Contrast-enhanced ...